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Excessive sugar intake has been related to cognitive alterations, but it remains unclear whether 
these effects are related exclusively to increased energy intake, and the molecular mechanisms 
involved are not fully understood. We supplemented Sprague-Dawley female rats with 10% w/v 
fructose in drinking water or with isocaloric glucose solution for seven months. Cognitive 
function was assessed through the Morris water maze (MWM) and the novel object recognition 
(NOR) tests. Plasma parameters and protein/mRNA expression in the frontal cortex and 
hippocampus were determined. Results showed that only fructose-supplemented rats displayed 
postprandial and fasting hypertriglyceridemia (1.4 and 1.9-fold, p<0.05) and a significant 
reduction in the discrimination index in the NOR test, whereas the results of the MWM test 
showed no differences between groups. Fructose-drinking rats displayed an abnormal glucose 
tolerance test and impaired insulin signaling in the frontal cortex, as revealed by significant 
reductions in insulin receptor substrate-2 protein levels (0.77-fold, p<0.05) and Akt 
phosphorylation (0.72-fold, p<0.05), and increased insulin-degrading enzyme levels (1.86-fold, 
p<0.001). Fructose supplementation reduced the expression of antioxidant enzymes and altered 
the amount of proteins involved in mitochondrial fusion/fission in the frontal cortex. In 
conclusion, cognitive deficits induced by chronic liquid fructose consumption are not exclusively 
related to increased caloric intake and are correlated with hypertriglyceridemia, impaired insulin 
signaling, increased oxidative stress and altered mitochondrial dynamics, especially in the 
frontal cortex. 
 




Metabolic diseases such as obesity, type 2 diabetes (T2D) and non-alcoholic steatohepatitis 
have been linked to cognitive disorders [1]. Specifically, cognitive decrements, i.e., slight 
changes in cognitive performance that do not interfere with daily life, have been observed not 
only in T2D patients, but also in individuals with pre-diabetic insulin resistance (IR) [2]. However, 
both metabolic and cognitive alterations are complex, multifactorial diseases, and 
epidemiological studies do not demonstrate a causal relationship between them or the 
mechanisms involved.  
It is widely acknowledged that a high intake of carbohydrates, particularly simple sugars, is 
associated with metabolic pathologies (obesity, IR and T2D) [3–6]. More recently, sugar intake 
has also been related to cognitive alterations [7–9]. The intake of simple sugars in the human 
diet has risen in the last decades and it is particularly high in industrialized countries, especially 
due to the elevated consumption of sugar-sweetened beverages (SSB) [10]. These beverages 
are usually sweetened with sucrose or with High Fructose Corn Syrup (HFCS), containing 
roughly 50% glucose and 50% fructose. Although glucose and fructose molecules are very 
similar, fructose seems to be more harmful than glucose to human health, due to its particular 
metabolic effects [11, 12]. In this sense, our research group has demonstrated that liquid 
fructose supplementation in rats for a two-month period causes worse metabolic and vascular 
responses than liquid glucose, despite the similar or even higher caloric intake of glucose-
supplemented rats [13, 14]. However, to our knowledge there are no reports comparing the 
effects of glucose and fructose on brain health. Moreover, it remains unclear whether these 
effects are related exclusively to the increased energy intake in individuals who consume large 
amounts of simple sugars. A population-based case-control study showed that a high caloric 
intake was associated with increased odds of developing mild cognitive impairment [15]. 
Nevertheless, the type of nutrient that provides these calories may also be a determining factor: 
a population-based prospective study performed with elderly subjects showed a higher risk of 
mild cognitive impairment or dementia in individuals who obtained a higher percentage of their 
daily calories from carbohydrates than from fat and proteins [16].  
  Female animals are underrepresented in preclinical studies, and there is increasing 
awareness by the National Institutes of Health (NIH) that research should include females. In 
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our previous studies we showed that female rats supplemented with liquid fructose displayed a 
more detrimental response than male rats, including glucose intolerance and insulin resistance, 
which were not observed in males [17]. Based on these results, and taking into account the 
putative relationship between metabolic abnormalities and cognitive alterations, in this study we 
used female Sprague–Dawley rats.  
  On the other hand, in our previous studies we used a two-month fructose or glucose 
supplementation period, which is roughly equivalent to six human years of daily sugar 
consumption [18]. However, the pattern of sugar-sweetened beverage consumption in humans 
may extend for much longer periods; in addition, both metabolic and cognitive alterations evolve 
over many years. Thus, in the present work we attempted to examine whether long-term (seven 
months) supplementation with liquid glucose or fructose, providing the same amount of calories, 
causes not only metabolic but also cognitive alterations in female rats, and to explore the 
molecular mechanisms involved.  
 
Materials and methods 
 Animals and diets  
   Female Sprague-Dawley rats were obtained from Charles River (Barcelona, Spain), 
and were maintained under conditions of constant humidity (40-60%) and temperature (20-
24ºC) with a light/dark cycle of 12 hours. Procedures were conducted in accordance with the 
guidelines established by the University of Barcelona’s Bioethics Committee (Autonomous 
Government of Catalonia Act 5/1995, of July 21). All experimental procedures involving animals 
were approved by the University of Barcelona’s Animal Experimentation Ethics Committee 
(approval No. 7912). 
36 adult rats (aged eight weeks) were randomly assigned to either a control group (no 
supplementary sugar, n=12), a fructose-supplemented group (10% w/v in drinking water) (n=12) 
or a group supplemented with a glucose solution prepared to match the amount of calories 
ingested by the fructose group (n=12), for seven months (28 weeks). All the animals received 
2014 Teklad rodent maintenance diet (Envigo, Barcelona, Spain). Throughout the treatment, the 
amount of solid food ingestion was controlled weekly and liquid consumption three times a 
week. Body weight was assessed every two weeks.    
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Glucose tolerance test  
A glucose tolerance test (GTT) was performed at week 26 after the beginning of the 
sugar supplementation period, as described previously [13]. Briefly, after a 6 h fast and 
following the collection of an unchallenged sample (time 0), a glucose solution of 2 g/kg body 
weight was administered into the peritoneal cavity. During the test, blood was collected from the 
tail vein at 15, 30, 60, 90 and 120 min after glucose administration. Glucose measurements 
were performed using a hand-held glucometer (Accutrend® Plus System Cobas, Roche Farma, 
Barcelona, Spain). Plasma insulin levels were measured at baseline, 15, 60 and 120 min post 
glucose administration using a rat insulin ELISA kit (Millipore, Billerica, MA, USA).  
 
Cognitive tests 
 Cognitive tests (novel object recognition (NOR) and Morris water maze (MWM) tests) 
were performed twice during the study, on week 2 and week 27 after the beginning of the sugar 
supplementation period.  
 The NOR task procedure consisted of habituation, familiarization and test phases. In the 
habituation phase, each animal was placed in an empty test arena (30x70x70 cm) and allowed 
to explore it for 10 min for two days. On the third day, each rat was placed in the same open-
field arena, which contained two identical objects (A + A), for 10 minutes (familiarization phase). 
After a retention interval of 2 h (first test) and 24 h (second test), the animal was returned to the 
arena with two objects, one of which was identical to the object used in the familiarization phase 
and the other was a novel object, for 10 minutes. The novel object was different in the first and 
second test (A+B and A+C, respectively). The behavior of the rats during the tests was 
recorded with a camera, and the time spent exploring the novel object (TN) and the old object 
(TO) measured. A discrimination index (DI) was defined as (TN − TO) / (TN + TO). The arena 
and objects were cleaned with 96° ethanol after each test in order to eliminate olfactory cues. 
 The MWM tests were performed two days after finishing the NOR tests, using an open 
circular pool (160 cm in diameter, 50 cm in height) half filled with water at a temperature of 22°C 
± 1. Two principal perpendicular axes were defined; thus, the water surface was divided into 
four quadrants (NE, SE, SW and NW), and five starting points were set (NE, E, SE, S and SW). 
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Four visual cues were placed on the walls of the tank (N, E, S and W). Non-toxic white latex 
paint was added to make the water opaque, and a white escape platform (11 cm in diameter) 
was submerged 1 cm below the water level (approximately in the middle of one of the 
quadrants). The position of the platform was different in the tests performed after two weeks 
and after seven months of sugar supplementation. The learning phase consisted of six days of 
trials for each rat. The animals were submitted to four trials each day and started from randomly 
set positions. There were no resting phases between trials. In each trial, the rat was gently 
placed in the water, facing the wall of the pool, and allowed to swim for 90 s. If the rat was 
unable to locate the platform during this period, it was guided or placed on the platform by the 
researcher. Animals were left on the platform for 30 s to allow them to spatially orient 
themselves. The animals' swimming paths were recorded by a video camera mounted above 
the center of the pool and the data were analyzed with SMART software version 3.0. The 
parameters measured were latency to find the platform, time spent in each quadrant and 
distance swam for each trial. A memory test was performed on day 7 whereby the platform was 
removed and the time spent by each rat in each quadrant measured. 
  
Sample preparation 
3 days after finishing the cognitive tests the rats were fasted 12 h. 8 rats from each 
group were anesthetized with ketamine/xylazine (9 mg and 40 µg/100 g body weight, 
respectively) and blood was collected by cardiac puncture. Plasma was prepared by 
centrifugation at 3,000 xg for 10 min at room temperature. The rats were then euthanized by 
exsanguination, their brains dissected, and the frontal cortex and the hippocampus separated, 
immediately frozen in liquid nitrogen, and stored at −80°C until needed.  
The remaining 4 rats in each group were used for immunohistochemical studies. To this 
end, the rats were intracardially perfused with 200 ml of 4% paraformaldehyde in 0.1 M 
phosphate buffer. The brains were then extracted and fixed in the same perfusion solution for 
24 h at 4ºC. The samples were maintained for 24 h in 4% paraformaldehyde / 30% sucrose 
solution, then frozen and stored at −80°C. 
 
Blood and plasma parameters  
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Triglycerides (post-prandial and after a 12 h fast) and fasting glucose levels were 
measured in blood samples using an Accutrend® Plus system glucometer (Cobas, Roche 
Farma, Barcelona, Spain). Concentrations of insulin and advanced glycation end products 
(AGE) in plasma were determined using specific enzyme-linked immunosorbent assay kits 
(Millipore, Billerica, MA, USA and MyBioSource, San Diego, CA, USA, respectively). 
Thiobarbituric acid reactive substance (TBARS) levels in plasma were determined using a 
colorimetric assay kit from Cayman (Ann Arbor, MI, USA). 
 
RNA preparation and analysis 
Total RNA was isolated with the TRIzol Reagent (Invitrogen, Carlsbad, CA, USA), in 
accordance with the manufacturer’s instructions. RNA concentration and purity were measured 
spectrophotometrically using the NanoDrop® ND-1000 Spectrophotometer (Thermo Scientific). 
The ratios of absorbance at 260/230 and 260/280 were used as indicators of RNA purity. 
Specific mRNAs were assessed by real-time reverse transcription polymerase chain reaction 
(RT-PCR) using SYBR Green PCR Master Mix, specific primers and the Applied Biosystems 
StepOnePlus Sequence Detection System (Applied Biosystems, Foster City, CA, USA). β-actin 
(actb) was used as an internal control. Primer sequences and PCR product length are listed in 
Supplementary Table 1. 
  
Preparation of protein extracts 
 Total protein extracts from the frontal cortex and hippocampus were obtained with the 
Helenius method [19]. Briefly, RIPA Lysis Buffer (Sigma-Aldrich, St. Louis, MO, USA) with 
protease, phosphatase and acetylase inhibitors (10 mM NaF, 1 mM EDTA, 1 mM EGTA, 2 mM 
Nappi, 1 mM PMSF, 2 µg/mL leupeptin, 2 µg/mL aprotinin, 1 mM Na3VO4, 10 mM NaM, 1 µM 
TSA) was added to micronized tissue and homogenized for 1.5 h at 4°C. The samples were 
then centrifuged at 15,000 ×g for 15 min at 4°C and the supernatant collected. Protein 
concentrations were determined using the Bradford method [20]. 
 
Western blot analysis 
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 Different protein extracts (20-30 µg) from rat frontal cortex and hippocampus were 
subjected to SDS-polyacrylamide gel electrophoresis. Proteins were then transferred to 
Immobilon polyvinylidene difluoride Transfer Membranes (Millipore, Billerica, MA, USA), blocked 
for 1 h at room temperature with 5% non-fat milk solution in Tris-buffered saline (TBS) with 0.1% 
Tween-20, and incubated as described previously [21]. Detection was performed using the ECL 
chemiluminescence kit for HRP (Amersham GE Healthcare Europe GmbH, Barcelona, Spain). 
To confirm the uniformity of protein loading, blots were incubated with -actin antibody (Sigma-
Aldrich, St. Louis, MO, USA), which was used as the normalization control for Western blot 
analysis. Primary antibodies for total and phosphorylated Akt, and total and phosphorylated 
GSK3β were supplied by Cell Signaling (Danvers, MA, USA), and those for Drp1, IDE, Mfn2 
and PSD95 were obtained from Abcam (Cambridge, UK). The anti-SYP antibody was obtained 
from Dako (Agilent Technologies, Santa Clara, CA, USA), Opa1 from BD Biosciences (San 
Jose, CA, USA), total Tau from Chemicon International (Temecula, CA, USA) and 
phosphorylated Tau from Invitrogen (Carlsbad, CA, USA).  
 
Brain-derived neurotrophic factor (BDNF) 
 Levels of BDNF protein were determined by an ELISA kit from Millipore (Billerica, MA, 
USA) using protein extracts from the frontal cortex and hippocampus.  
 
Glial fibrillary acidic protein (GFAP) detection by immunohistochemistry 
Frozen brains were embedded in OCT cryostat embedding compound (Tissue-Tek, 
Torrance, CA, USA), cut into 25 μm-thick coronal sections using a cryostat (Leica 
Microsistemas, Barcelona, Spain) at −23°C, and placed on slides. The slides were stored at -
20ºC in 0.1 M phosphate buffer containing 30% glycerol and 30% ethyleneglycol. For the 
staining procedure, the brain sections were incubated for 2 h at room temperature with a 
blocking solution (0.1 M phosphate buffer containing 10% fetal bovine serum, 1% Triton and 
0.2% gelatin). The slices were then incubated overnight at 4°C with an anti-GFAP antibody 
(Dako, Agilent Technologies, Santa Clara, CA, USA). Next, the samples were incubated with a 
fluorescent secondary antibody (Anti-Rabbit IgG Alexa Fluor 594, Life Technologies, Thermo 
Fisher Scientific, Waltham, MA, USA) diluted in blocking solution for 2 h at room temperature. 
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Nuclear staining was performed with 2 µg/mL of Hoechst H33342 (Sigma-Aldrich, Saint Louis, 
MO, USA) for 8 min at room temperature, and the sections were then mounted with 
Fluoromount-G™ (EMS, Hatfield, NJ, USA). Slides were allowed to dry overnight and images 
were acquired with a fluorescence laser microscope (Olympus BX41; Olympus, Hamburg, 
Germany). At least four images from four different animals per group were analyzed using 
ImageJ/ 1.49v software, available online from the National Institutes of Health, USA. 
 
Statistical analysis 
  The results are expressed as the mean of n values ± standard deviation. Plasma 
samples were assayed in duplicate. Gaussian distribution of the data was verified using the 
Kolmogorov-Smirnov normality test, and significant differences were established by one-way 
ANOVA and Šidák’s post-hoc test for selected comparisons (GraphPad Software V6). When 
variance was not homogeneous, a non-parametric test was performed. In addition, partial 
correlation after controlling for group was calculated using SPSS+ 21.00, between the variables 
of interest (see figure legend for details). Spearman’s partial correlation coefficients between 
each possible pair of behavioral markers, plasma levels or neuronal markers were calculated 
with adjusted p-values to eliminate false positive correlations. The statistical significance level 
was set at p≤0.05. 
 
Results 
Only fructose supplementation increases body weight and plasma triglyceride, AGE and 
TBARS levels, despite the identical total calorie consumption of the glucose group 
  Rats supplemented with liquid glucose or fructose for seven months drank more than 
control rats (3.2- and 2.7-fold, respectively) and reduced their ingestion of solid food (0.6- and 
0.7-fold, respectively) (Table 1). This reduction was not sufficient to compensate for the calories 
obtained from the sugars, and the total caloric intake was therefore increased by similar levels 
in both glucose and fructose groups (1.6 and 1.5-fold, respectively). However, only fructose-
supplemented rats showed an increase in body weight throughout and at the end of the 
treatment period (Table 1). Moreover, only fructose-supplemented rats displayed postprandial 
 10 
and fasting hypertriglyceridemia (1.4 and 1.9-fold) and increased levels of AGE (1.9-fold) and 
TBARS (1.5-fold).  
 
Fructose but not glucose supplementation reduces whole-body insulin sensitivity and 
alters the glucose tolerance test 
  As shown in Figures 1A and B, despite the fact that blood glucose levels were not 
altered, fructose-supplemented rats showed significant hyperinsulinemia at the end of 
treatment. The insulin sensitivity index therefore decreased significantly in this group only 
(Figure 1C). The results of the GTT showed an increase in blood glucose levels 120 min after 
the glucose challenge in the fructose group only (Figure 1D), but the integrated glucose 
concentration, calculated as the area under the curve (AUC), was not significantly altered 
(Figure 1E). However, glucose-stimulated AUC insulin levels increased significantly in fructose-
supplemented rats only (Figures 1F and 1G).  
 
Fructose-supplementation for seven months impairs novel object recognition 
 Rats were assessed in the NOR and MWM tests at the beginning (week 2) and at the 
end (week 27) of the sugar supplementation in order to study the short- and long-term effects 
on memory, respectively. The results of the NOR tests performed at week 2 did not reveal any 
effect on memory, since no differences were detected in the discrimination index (DI) between 
groups (Figures 2A and 2B). By contrast, the NOR tests performed at week 27 showed a 
significant reduction in the discrimination index in the fructose group only (Figures 2C and 2D).  
The results of the MWM test showed no differences in spatial-learning acquisition and retention 
between the different experimental groups at the two time-points examined. Thus, all groups 
were able to learn over the course of the trial period (Figures 3A and 3 E) and the swimming 
velocity was similar (Figures 3B and 3F). The removal test showed no differences in the 
percentage of time spent in the platform quadrant (Figures 3C and 3G) or in the number of 
entries into the platform zone (Figures 3D and 3H).  
 
Effects of sugar supplementation on synaptic plasticity-related parameters 
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 Next, we determined the expression of several molecules involved in the regulation of 
synaptic plasticity, a mechanism underlying the acquisition and consolidation of learning and 
memory. The protein expression of brain-derived neurotrophic factor (BDNF) was reduced 
significantly by fructose supplementation in the hippocampus and also showed a trend towards 
a reduction in the frontal cortex of this group (Figure 4A). However, the expression of other 
molecules also related to synaptic plasticity, such as synapsin1 (SYN1), growth-associated 
protein 43 (GAP-43), synaptophysin (SYP) and PSD95, was not altered by sugar 
supplementation (Figures 4B-D).  
 
Fructose, but not glucose, alters brain insulin signaling 
 It has been suggested that insulin signaling in the brain is involved in cognitive functions 
such as learning and memory [22]. Thus, the reduction in whole-body insulin sensitivity and the 
altered results of the NOR test in fructose-drinking rats prompted us to examine insulin signaling 
in the frontal cortex and the hippocampus. The mRNA expression of the main insulin-signaling 
transducers, insulin receptor substrates (IRS)-1 and -2, was not significantly modified (Figure 
5A). However, we found that IRS-2 protein expression in the frontal cortex was significantly 
reduced in fructose-supplemented rats (Figure 5B). Moreover, phosphorylation of V-akt murine 
thymoma viral oncogene homolog-2 (Akt) was also significantly reduced in the frontal cortex of 
the fructose group (Figure 5C). A trend towards reduced Akt phosphorylation in the 
hippocampus was also observed, but did not reach statistical significance (Figure 5D). The 
phosphorylation status of Akt-downstream molecules glycogen synthase kinase (GSK)3β and 
Tau was not affected by sugar supplementation in either the frontal cortex or the hippocampus 
(Figures 5C and 5D). 
The expression of insulin-degrading enzyme (IDE), a protease involved in the 
degradation of both insulin and amyloid β (Aβ), was also determined. Rats supplemented with 
fructose showed a significant increase (1.8-fold, p<0.001) in the IDE protein levels in the frontal 
cortex, but not in the hippocampus (Figure 5E).  
   
Sugar supplementation does not induce neuroinflammation in the frontal cortex or the 
hippocampus 
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Neuroinflammation is one of the mechanisms that may underlie cerebral insulin 
resistance. However, the mRNA expression of pro-inflammatory molecules tumor necrosis 
factor (tnf) α, monocyte chemotactic protein (mcp)-1 and interleukin (il)-6 were not significantly 
modified after sugar supplementation in either the frontal cortex or the hippocampus (Figure 
6A). Moreover, the immunohistochemical assessment of glial fibrillary acidic protein (GFAP) 
expression, a marker of astroglial activation, did not reveal any differences between groups in 
the frontal cortex or the hippocampus (Figures 6B and 6C).  
 
Effects of fructose supplementation on oxidative stress and markers of mitochondrial 
dynamics 
 Increased production of reactive oxygen species (ROS) and oxidative stress have also 
been related to the establishment of insulin resistance. We examined the mRNA expression of 
glutathione peroxidase (gpx1), a major peroxide-scavenging enzyme, superoxide dismutase 
(sod2), which converts superoxide into hydrogen peroxide, and catalase (cat), which is 
responsible for the decomposition of hydrogen peroxide to water and oxygen. Our results 
showed that the mRNA levels of gpx1, sod2 and cat in the frontal cortex of fructose-
supplemented rats were significantly reduced; however, in the hippocampus, only sod2 mRNA 
expression decreased significantly in the fructose group (Figure 7A). 
 As mitochondrial dysfunction has also been related to impaired neuronal function, the 
expression of mitochondria-shaping proteins optic atrophy 1 (Opa1) and mitofusin 2 (Mfn-2), 
which promote mitochondrial fusion, and dynamin-related protein 1 (Drp1), which participates in 
mitochondrial fission, was determined. As shown in Figure 7B, fructose supplementation 
significantly reduced Opa1 expression in the frontal cortex, whereas it increased the expression 
of Drp1, which suggests impaired mitochondrial dynamics. By contrast, glucose 
supplementation did not alter the expression of these proteins significantly. None of these 
proteins was affected by sugar supplementation in the hippocampus (Figure 7C). 
  
Cognitive alterations are associated with metabolic changes 
 A partial correlation analysis was performed in order to determine the relationship 
between the DI (the parameter used to assess the performance of the rats in the NOR test) and 
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several metabolic and molecular parameters that may be related to key events in 
neurodegeneration processes, after seven months of sugar supplementation (Supplementary 
Table 2 and Figure 8). The most interesting findings were a significant negative correlation 
between the DI and plasma triglyceride values (r=-0.650, p<0.001) and a positive correlation 
between triglyceride and insulin plasma levels (r=0.493, p<0.05), which suggests that 
hypertriglyceridemia may contribute to the cognitive impairment and also to the 
hyperinsulinemia observed in fructose-supplemented rats. Moreover, we found significant 
correlations between the DI and the expression of molecules related to oxidative stress (Sod2: 
r=0.462, p<0.05) and mitochondrial dynamics (Opa1: r=-0.877, p<0.001 and Drp1: r=0.825, 
p<0.001) in the frontal cortex. 
 
Discussion  
  Diet-induced cognitive deficits and their relationship with metabolic alterations have been 
the subject of extensive research, but it is still a matter of debate whether these effects depend 
exclusively on the high amount of energy provided by the diets or are related to specific 
nutrients. Our results support the latter, as they show that long-term exposure to a diet 
supplemented with liquid fructose in female rats causes metabolic and cognitive alterations, 
whereas consumption of an isocaloric supplement of liquid glucose does not. Specifically, only 
fructose consumption alters the results of the GTT and impairs brain insulin signaling, while 
reducing the rats’ performance in the NOR test. Moreover, only fructose-supplemented rats 
exhibit increased plasma levels of triglycerides, AGE and TBARS, as well as reduced 
expression of antioxidant enzymes and altered mitochondrial dynamics in the frontal cortex.  
  In humans, some reports suggest impaired postprandial memory after consumption of a 
meal with a high glycemic index [23–25], whereas others show that drinking glucose can 
temporarily enhance cognitive abilities [26, 27]. By contrast, our results did not show any 
differences in cognitive performance in the MWM or NOR tests after short-term sugar 
supplementation (2 weeks). However, when the sugar supplementation period was extended to 
seven months, memory deficits were observed in the NOR test, but not the MWM test, and only 
in animals that consumed fructose. Most studies concerning the effects of dietary components 
on cognitive abilities in animal models use only one type of test, but it has been suggested that 
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memory impairments after simple sugar consumption may differ depending on the cognitive test 
used [28]. The NOR test is based on the rodents’ spontaneous preference for novelty, and it is a 
widely used model for researching memory alterations through the evaluation of the animals’ 
ability to recognize a novel object [29]. The MWM test, on the other hand, evaluates spatial 
working memory and learning, and is considered useful for assessing damage to the 
hippocampus [30]. Hippocampal tissue seems to be play a more important role in spatial 
memory than in non-spatial memory [31], which is evaluated more effectively in the NOR test. In 
most studies, the NOR task does not seem to be impaired by hippocampal lesions [32]. Thus, 
the memory deficits observed in our study, in the NOR test alone, suggest that the main effect 
of fructose supplementation does not take place in the hippocampus. However, the involvement 
of this tissue in the cognitive alterations observed cannot be ruled out entirely, since it has been 
shown that with retention intervals of less than 15 min in the NOR test the cortex is sufficient for 
object recognition, but with longer intervals (as in the present study, i.e., 2 and 24 h), the 
hippocampus is also required [31].  
  In that regard, the levels of BDNF protein, a neurotrophic factor that plays an important 
role in synaptic plasticity, were found to be lower in both the frontal cortex and the 
hippocampus, and the reduction was more intense and significant in the hippocampus. Although 
it has been reported that BDNF levels are regulated by excessive dietary energy [33], our 
results clearly show a specific reduction in fructose-supplemented rats, despite the fact that the 
energy intake was identical in both sugar-supplemented groups. Several studies in laboratory 
animals suggest that diets enriched with sugars and fats lead to a reduction in BDNF levels that 
correlates with cognitive decline [33, 34]. In humans, reduced BDNF expression is already 
evident in pre-clinical phases of Alzheimer’s disease (AD) [31]. Thus, the observed reduction in 
hippocampal BDNF may be an early marker of dysfunction that appears before specific 
hippocampus-related cognitive deficits are apparent. Moreover, our results show that 
downstream effectors of the BDNF pathway (SYN1 and GAP43) are not affected in sugar-
supplemented rats. Thus, it is plausible that longer supplementation with fructose could lead to 
further impairment of BDNF signaling, thereby resulting in memory deficits in the MWM test. 
However, not only the duration of the sugar supplementation period, but also the sex of the 
animals may influence the rats’ performance in a given test. For example, cognitive deficits in 
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the spatial water maze test were observed in male rats supplemented with high-fructose diets 
for four to five months [35, 36], but not in female rats [37]. This suggests that estrogens may be 
protective against the development of these alterations [9].  
  One key observation of the present study is that, despite being isocaloric, fructose 
supplements caused cognitive alterations, while glucose supplements did not. This is consistent 
with the presence of metabolic alterations in fructose-supplemented rats only, which reveals the 
mechanism underlying the cognitive deficits. On the one hand, rats supplemented with fructose 
present clear hypertriglyceridemia, which is not observed in glucose-supplemented rats, and 
there is a strong negative correlation between the DI obtained in the NOR test and the plasma 
triglyceride levels after seven months of sugar supplementation (Table 2, Figure 8). Thus, our 
results are consistent with studies showing that high triglyceride levels can cause cognitive 
alterations [38–40]. On the other hand, only rats that received fructose present significant 
increases in plasma insulin levels, under fasting conditions and throughout the GTT, which 
indicates that the rats may secrete more insulin in order to maintain normal blood glucose 
levels. Accordingly, fructose-drinking rats show a reduction in whole-body insulin sensitivity, 
assessed by the ISI, which suggests a state of IR. Studies in hamsters also show that fructose 
induces an IR state, together with a considerable increase in VLDL-triglyceride production, and 
suggest that the culprit for these effects is not fructose per se but the IR caused by fructose 
[41]. In this regard, a significant positive correlation was observed between plasma triglyceride 
and insulin levels (Table 2, Figure 8). Moreover, IR is a hallmark of T2D, and clinical studies 
have linked pre-diabetic IR states and T2D to cognitive dysfunctions and dementia [2]. It has 
been suggested that peripheral IR is accompanied by central IR, which may be a mechanistic 
mediator of cognitive deficits [2, 42].  In the present study, we observed that fructose- but not 
glucose-supplemented rats show insulin signaling impairment in the brain, once again 
suggesting that the effect is specifically related to fructose rather than increased calorie intake. 
A hippocampal insulin signaling defect has previously been observed in fructose-fed rats or 
hamsters [35, 43, 44]. Our results are consistent with these reports, as they show a trend 
towards reduced Akt phosphorylation in the hippocampus in the context of increased plasma 
insulin, a situation in which activation of Akt would be expected. Most studies concerning diet-
induced central IR have focused on the hippocampus, as this tissue expresses high levels of 
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insulin receptors [45] and is particularly sensitive to changes in lifestyle factors, such as diet [33, 
46]. However, all components of the insulin signaling cascade are also expressed to a 
comparable extent in the cortex [47], and dietary changes may also affect this brain region. 
Indeed, we examined insulin signaling in the frontal cortex also, and observed a clear 
impairment, revealed by significantly reduced IRS-2 protein levels and Akt phosphorylation. It 
could be hypothesized that the memory deficit observed in the NOR task, which as commented 
before depends less on the hippocampus than the cortex, may be related to the more intense 
insulin signaling impairment in this brain region. These results highlight the importance of the 
cortex, which has received less attention than the hippocampus in past studies, in the 
establishment of cognitive deficits induced by fructose supplementation. 
  IR has been associated with decreased IDE levels [22, 48]; by contrast, we observed an 
increase in IDE protein expression in fructose-drinking rats. Insulin has been shown to regulate 
IDE expression [49], and the hyperinsulinemia presented by the fructose group could therefore 
explain this increase. Alternatively, increased IDE may be regarded as a compensatory 
mechanism to reduce high insulin levels due to its insulin-degrading activity. Some reports 
suggest an inverse correlation between plasma and cerebrospinal fluid insulin in AD patients 
[47]. Thus, although brain insulin levels were not measured in this study, it could be 
hypothesized that increased IDE expression in fructose-supplemented rats leads to reduced 
insulin concentrations in the brain, thereby contributing to impaired insulin signaling and 
cognitive deficits. 
  Other factors, such as inflammation and oxidative stress, may play a key role in cognitive 
dysfunctions, either directly or through IR-related mechanisms [2]. Our results, which show 
unaltered expression of the main inflammatory mediators and astrogliosis markers, rule out the 
participation of neuroinflammation in our model. In contrast, Cigliano et al. recently reported 
hippocampal inflammation in young and adult male rats after short-term consumption of fructose 
in solid form [44], and suggested that inflammation may be linked to increased intestinal 
permeability and microbiota remodeling [44, 50]. The difference between our results and those 
from Cigliano et al. may lie in the way the body handles solid compared to liquid fructose; thus, 
we have previously shown that feeding mice with a Western-type solid diet as a source of 
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fructose increases intestinal permeability to bacterial toxins, whereas liquid fructose 
supplementation (15% w/v) does not [51].  
  On the other hand, plasma AGE levels are selectively increased in fructose-drinking rats 
(Table 1), thus highlighting a role for oxidative stress. In this regard, the formation of AGEs 
(irreversible adducts derived from the non-enzymatic reaction between sugars, such as glucose 
and fructose, and proteins) increases under oxidative conditions [52] and, in a positive feedback 
loop, AGEs may increase the formation of reactive oxygen species [53] and down-regulate 
intracellular antioxidant systems, such as SOD and glutathione [54]. In this regard, a reduction 
in the mRNA expression of antioxidant enzymes in the frontal cortex of fructose-supplemented 
rats was observed, and this may contribute to increased oxidative stress. Accordingly, plasma 
TBARS levels, a marker of lipid peroxidation that occurs as a consequence of oxidative 
imbalance [55], increase only in the fructose group. The fact that both AGE and TBARS are 
selectively increased by fructose but not glucose supplementation may derive from fructose-
specific mechanisms, such as its higher reactivity to form AGE compared with glucose [56]. 
Moreover, an increase in TBARS may result from fructose-increased triglyceride levels, as 
serum triglycerides have been shown to positively correlate with the amount of TBARS [57].  
On the other hand, oxidative stress-related neurodegenerative diseases, such as AD and age-
related cognitive disorders, are also characterized by dysfunctions in mitochondrial dynamics 
[58, 59]. Specifically, excessive mitochondrial fission resulting in fragmented mitochondria is an 
early event in the progression of these pathologies [60] and has also been observed in the 
neurons of diabetic mice [61]. Our results also show an increase in the expression of the fission-
related protein Drp1 and a decrease in Opa1, which is involved in the fusion process, in the 
frontal cortex of fructose-drinking rats. Although mild, these changes suggest that fructose 
induces an imbalance in mitochondrial dynamics in this area of the brain that may result from 
increased oxidative stress and can further contribute to it, in a vicious cycle leading to the 
progression of cognitive dysfunction.   
  In conclusion, our results show that fructose supplementation in liquid form induces 
cognitive deficits in female rats that are strongly associated with metabolic alterations, 
specifically hypertriglyceridemia, hyperinsulinemia and changes in molecular markers of 
oxidative stress and mitochondrial dynamics. These alterations, which are absent in isocaloric 
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glucose-supplemented rats and are therefore not exclusively related to the increased calorie 
intake, could underlie defects in molecular pathways, such as brain insulin signaling, and lead to 
cognitive impairment.  
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Figure 1: Blood glucose (A), plasma insulin levels (B) and insulin sensitivity index (C) from 
control (CT), glucose- (GLC) and fructose-supplemented rats (FRC). (D-G) Results of the 
glucose tolerance test: plasma glucose (D) and insulin (F) values at different times after the 
intraperitoneal administration of a glucose solution (2 g/kg body weight). Area under the curve 
(AUC) values for glucose (E) and insulin (G) plasma concentrations represented in Fig 1D and 
F. Results are the mean ± SD of values from 11-12 animals/group. *p < 0.05, **p < 0.01 vs CT; 
#p < 0.05, ##p < 0.01, ###p < 0.001 vs GLC. 
 
Figure 2: Results of the Novel Object Recognition (NOR) Test. The bars show the performance 
of control (CT), Glucose- (GLC) and Fructose-supplemented (FRC) rats in the test measured as 
Discrimination Index (DI) 2 h and 24 h after the training phase,  at  week 2 (A,B) and  week 27 
(C,D) after the commencement of their respective diets. The DI was defined as (TN − TO) / (TN 
+ TO), being TN and TO the time spent by each rat exploring the novel object and the old 
object, respectively. Results are the mean ± SD of values from 11-12 animals/group. *p < 0.05 
vs CT; #p < 0.05, ##p < 0.01 vs GLC. 
 
Figure 3: Evaluation of spatial learning and memory performance of control (CT), Glucose- 
(GLC) and Fructose-supplemented (FRC) rats using the Morris Water Maze (MWM) Test at 
week 2 (A-D) and week 27 (E-H) after the commencement of their respective diets. The bars 
show the escape latency time to reach the hidden platform during training days (A,E) and the 
swimming velocity (B,F), the percentage of time spent in the platform zone (C,G) and the 
number of entries in the platform zone (D,H) during the probe trial. Results are the mean ± SD 
of values from 11-12 animals/group. *p < 0.05 vs CT; #p < 0.05, ##p < 0.01 vs GLC. 
 
Figure 4. (A) Levels of BDNF in the frontal cortex and in the hippocampus of control and sugar-
supplemented rats determined by ELISA test. (B) mRNA levels of SYN1 and GAP43 in the 
frontal cortex and in the hippocampus of control and sugar-supplemented rats (n=8/group).  
Western-blot of SYP and PSD95 in samples from the frontal cortex (C) and the hippocampus 
(D) obtained from control, glucose- and fructose-supplemented rats. Representative bands 
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corresponding to 3 different rats in each group are shown; bar plots show the level of the 
proteins expressed as the mean (a.u., arbitrary units) ± SD of the values obtained from 4-5 
animals. *p < 0.05 vs control values; #p < 0.05 vs glucose group values.  
 
Figure 5. (A) mRNA levels of IRS-1 and -2 in the frontal cortex and in the hippocampus of 
control and sugar-supplemented rats (n=8/group). Western-blot of IRS-2 (B), phosphorylated 
and total AKT, GSK3β and TAU (C,D) and IDE (E) in samples from frontal cortex and 
hippocampus obtained from control, glucose- and fructose-supplemented rats. Representative 
bands corresponding to 3 different rats in each group are shown; bar plots show the level of the 
proteins expressed as the mean (a.u., arbitrary units) ± SD of the values obtained from 4-5 
animals. *p < 0.05, ***p<0.001 vs control values; #p < 0.05, ##p <0.01 vs glucose group values.  
 
Figure 6. (A) Bar plots showing the relative levels of specific mRNAs of pro-inflammatory 
molecules in the frontal cortex and in the hippocampus of control and sugar-supplemented rats 
(n=8/group). (B) Quantification and (C) representative images for GFAP immunostaining in 
control fructose- and glucose-supplemented rats. Bars represent the mean (a.u., arbitrary units) 
± SD of the values obtained from 4-5 animals/group. CA: Cornu Amonis, DG: Dentate gyrus.  
 
Figure 7. (A) Bar plots showing the relative levels of specific mRNAs of oxidative stress-related 
molecules in the frontal cortex and in the hippocampus of control and sugar-supplemented rats 
(n=8/group). Western-blot of proteins involved in mitochondrial dynamics in the frontal cortex (B) 
and hippocampus (C) obtained from control, glucose- and fructose-supplemented rats. 
Representative bands corresponding to 3 different rats in each group are shown; bar plots show 
the level of the proteins expressed as the mean (a.u., arbitrary units) ± SD of the values 
obtained from 4-5 animals. *p < 0.05 vs control values. Verificar asterisk en aquesta figura 
 
Figure 8. Behavioral, plasma level and neuronal markers hierarchical network of the three rat 
groups (n=36) obtained by using yEd graph editor (v. 3.14.4). Each node represents one 
behavioral, plasma level or neuronal marker and each edge between two nodes represents the 
partial correlation. Colors represent the different variables and node dimensions represent the 
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number of correlations. Solid black line represents positive correlation and dotted red line 








Table 1. Zoometric parameters and plasma analytes of female rats supplemented or not with 
10% w/v liquid fructose or glucose for 7 months. 
 
 
Control Glucose Fructose 
AUC liquid intake 
(ml/[rat x 7 months])a  
7171±923 22935±3340*** 19712±5040** 
AUC solid food intake  
(g/[rat x 7 months])a 
3190±154 1899±225*** 2139±310*** 
AUC Total ingested kcal 
(kcal/[rat x 7 months])a 
9331±443 14705±820*** 14119±1430*** 
Final body weight 
(g) a 
327±23 344±17 359±38* 
AUC weight 
(g/[rat x 7 months])a 
8103±445 8267±362 8623±566* 
Postpandrial plasma triglycerides  
(mg/dl) 
144±24 147±16 209±45***### 
Fasting plasma triglycerides  
(mg/dl) 
155±27 196±50 292±28***### 
Plasma AGE  
(ng/ml) 
12.2±4.2 9.8±6.7 22.9±6.9* 
Plasma TBARS 
(µmol/l) 
23.2±5.0 25.3±4.3 34.1±7.3*# 
 
AUC: Area Under the Curve. Values are expressed as mean ± SD of n=8 rats/group except for 
valuesa, which were obtained from n=12 rats. *p<0.05; **p<0.01;***p<0.001 vs Control and 
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